BDX vs GEMI · P/E 34, rev $21.84B vs rev $50.6M
Becton Dickinson and Company (BDX) versus Gemini Space Station, Inc. Class A Common Stock (GEMI) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Gemini Space Station, Inc. Class A Common Stock (GEMI) is a capital markets company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported GEMI revenue for 2025-09-30 was $50.6M. Net income was -$159.5M. Revenue was up 106.3% from 2024-09-30 to 2025-09-30. GEMI currently screens at market cap $630.9M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. GEMI currently screens at market cap $630.9M.
Not investment advice. Open the BDX and GEMI stock pages for the full models.
Not investment advice.